Open Access

Expression levels and prognostic values of annexins in liver cancer

  • Authors:
    • Chunbo Zhuang
    • Pei Wang
    • Ting Sun
    • Lei Zheng
    • Liang Ming
  • View Affiliations

  • Published online on: October 30, 2019     https://doi.org/10.3892/ol.2019.11025
  • Pages: 6657-6669
  • Copyright: © Zhuang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Annexins are a superfamily of calcium‑dependent phospholipid‑binding proteins that are implicated in a wide range of biological processes. The annexin superfamily comprises 13 members in humans (ANXAs), the majority of which are frequently dysregulated in cancer. However, the expression patterns and prognostic values of ANXAs in liver cancer are currently largely unknown. The present study aimed to analyze the expression levels of ANXAs and survival data in patients with liver cancer from the Oncomine, GEPIA, Kaplan‑Meier plotter and cBioPortal for Cancer Genomics databases. The results demonstrated that ANXA1, A2, A3, A4 and A5 were upregulated, whereas ANXA10 was downregulated in liver cancer compared with normal liver tissues. The expression of ANXA10 was associated with pathological stage. High expression levels of ANXA2 and A5 were significantly associated with poor overall survival (OS) rate whereas ANXA7 and A10 were associated with increased OS. The prognostic values of ANXAs in liver cancer were determined based on sex and clinical stage, which revealed that ANXA2, A5, A7 and A10 were associated with OS in male, but not in female patients. In addition, the potential biological functions of ANXAs were identified by Gene Ontology functional annotation and Kyoto Encyclopedia of Genes Genomes pathway analysis; the results demonstrated that ANXAs may serve a role in liver cancer through the neuroactive ligand‑receptor interaction pathway. In conclusion, the results of the present study suggested that ANXA1, A2, A3, A4, A5 and A10 may be potential therapeutic targets for liver cancer treatment, and that ANXA2, A5, A7 and A10 may be potential prognostic biomarkers of liver cancer.
View Figures
View References

Related Articles

Journal Cover

December-2019
Volume 18 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhuang C, Wang P, Sun T, Zheng L and Ming L: Expression levels and prognostic values of annexins in liver cancer. Oncol Lett 18: 6657-6669, 2019.
APA
Zhuang, C., Wang, P., Sun, T., Zheng, L., & Ming, L. (2019). Expression levels and prognostic values of annexins in liver cancer. Oncology Letters, 18, 6657-6669. https://doi.org/10.3892/ol.2019.11025
MLA
Zhuang, C., Wang, P., Sun, T., Zheng, L., Ming, L."Expression levels and prognostic values of annexins in liver cancer". Oncology Letters 18.6 (2019): 6657-6669.
Chicago
Zhuang, C., Wang, P., Sun, T., Zheng, L., Ming, L."Expression levels and prognostic values of annexins in liver cancer". Oncology Letters 18, no. 6 (2019): 6657-6669. https://doi.org/10.3892/ol.2019.11025